Your session is about to expire
← Back to Search
Memantine for Alzheimer's Disease
Study Summary
This trial will test whether memantine can improve brain function and reduce symptoms in Alzheimer's Disease.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are currently participating in cognitive therapy.I have been diagnosed with Alzheimer's disease by a research center.Your memory and thinking test scores are between 10-22 for MMSE or 15-24 for MOCA.I am between 50 and 83 years old.You can hear sounds at a level of 40 decibels or less at 1000 Hertz.You have used illegal drugs that were not prescribed by a doctor.I am currently taking medications like amantadine, riluzole, or opioids.I have taken memantine and cannot tolerate acetylcholinesterase inhibitors.I have a history of heart or brain vascular issues, seizures, head injuries with unconsciousness, or substance dependence.I do not have any active serious illnesses like heart disease or liver failure.You have a mental or brain-related illness other than Alzheimer's disease.I haven't taken any experimental drugs in the last 30 days.I can walk on my own without help.
- Group 1: Memantine
- Group 2: Placebo
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Am I eligible to enroll in this research study?
"This clinical trial is looking for 88 participants that have a confirmed diagnosis of Alzheimer's disease from the Alzheimer's Disease Research Center. Patients must also score between 10-22 on the Mini-Mental State Examination or 15-24 on the Montreal Cognitive Assessment. Furthermore, patients must be within the age range of 50-83, have a knowledgeable caregiver, be ambulatory, and have no active psychiatric or neurologic illnesses. Lastly, patients must be able to pass audiometric testing and provide informed consent."
Has Memantine been cleared by the FDA?
"Memantine has completed Phase 4 trials, meaning it has been approved, and thus it receives a score of 3 for safety."
Does Memantine have a history of therapeutic efficacy?
"Currently, there are 27 different ongoing studies investigating Memantine. Of those, 11 are in the final stages before FDA approval. Most of the trials are based in Geneva, Illinois, but there are 291 total locations running studies."
What is the maximum amount of people that can enroll in this research project?
"That is correct. The clinical trial is currently recruiting, as indicated by the data on clinicaltrials.gov. The trial was first posted on 1/31/2019 and was last edited on 4/8/2022. The study needs 88 participants from 1 site."
Does this experiment have an age limit? If so, what is the upper age limit for participants?
"People aged 50 to 83 who meet the other inclusion criteria may participate in this clinical trial. There are 565 trials for people over 65 and 26 for people under 18."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger